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Abstract
Background: In South Africa, not much is known about MetS in farm working communities. This study aimed to
describe the prevalence of the MetS in a farm working population from the Boland winelands district of the
Western Cape, South Africa.
Methods: A cross-sectional study was followed among farm workers (aged 20–60 years) from surrounding wine
estates. The questionnaires used described socio-demographic status, ethnic background, alcohol consumption,
smoking, exercise and daily medication. Anthropometric assessments were performed and blood pressure
measurements taken prior to blood sampling for serum insulin, glucose and fasting lipogram profiles.
Results: The prevalence of the MetS was higher in women (46.3 vs 29.3%). Both men and women in the MetS
group had a significantly higher waist circumferences (WC; p < 0.001 for both), whilst higher glucose levels were
only significantly higher in the women (p < 0.001). Correlations showed significant differences between body mass
index (BMI), WC and waist to hip ratio (W:H) and the different MetS risk factors.
Conclusions: The female population in this study showed higher prevalence rates for the individual risk factors and
the MetS overall. There is an urgent need to develop culturally sensitive health promotion programs addressing risk
factors for metabolic syndrome among farm workers.
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Background
The metabolic syndrome (MetS) is a cluster of risk fac-
tors that are mostly associated with people living with
obesity and diabetes [1], with the prevalence of the MetS
varying between different populations. Davila et al. [2]
established that the prevalence of the MetS is not only
increased in shift workers, but also among farm workers
in the United States. One specific study from the African
continent also highlighted urbanisation as a crucial
factor in the prevalence of the MetS, especially in Sub-
Saharan Africa [3]. South African data (CRIBSA) sug-
gested a high prevalence among urban black populations
[4]. This is mostly attributed to the nutrition transition
[5] that contributes towards changes in dietary behav-
iour, social and psychological shifts. Although a limited
number of studies are available regarding the prevalence of
the MetS, not much is documented in the South African
context. A further complication is the use of different MetS
definitions. Here, it ranges from insulin resistance being re-
ported to waist circumference (WC) not being reported.
Motala et al. [6] reported an overall high prevalence of the
MetS in rural women (30.2%) in South Africa. A study in
an urban area in Cape Town revealed the prevalence of the
MetS to be 60.6% (IDF definition) in 2012, and more asso-
ciated with the coloured female population [7]. Age-
adjusted prevalence of central obesity was also higher in
women from rural (farming areas) vs urban areas [8].
There is also currently limited to no South African litera-
ture available on the prevalence of the MetS among farm
workers. The aim of this study thus was to describe the
prevalence of the MetS, as well as to highlight possible as-
sociations between selected parameters, in a farm worker* Correspondence: maritza@sun.ac.za; kruger.maritza@gmail.com
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A cross-sectional study was followed among workers
from the surrounding wine estates in the Stellenbosch
Municipal area, Western Cape Province of South
Africa. Meetings were held on each of the respective
farms prior to study commencement at which time
the study was thoroughly explained. Thereafter data
was collected from volunteering participants of both
genders that met the inclusion criteria from either
Villiera-, Neethlinghshof wine estates, and Solms-
Delta wine estate in the Franschoek Municipal area.
Participants that were successfully recruited had to be
from the Stellenbosch and surrounding area and also
between 20 and 60 years old. Pregnant and/or lactat-
ing women were excluded at the time of data collec-
tion. Individuals that were unable to provide written
consent were also excluded from the study.
Data collection and questionnaires
All volunteers were informed of all testing procedures
and what is expected from them. Information regarding
socio-demographic status was obtained by means of a
specifically designed questionnaire. The demographic
questionnaire included questions regarding the number
of people residing in the house, the type of house, home
language and literacy, nearest clinic, and average
monthly or weekly income. Specific questions regarding
age, gender, ethnic background, alcohol consumption,
smoking, exercise and daily medication were also
included.
Conventional anthropometry was performed in dupli-
cate, including base measurements (height and weight)
and circumferences (waist and hip). All measurement
data was obtained using standardised techniques and
calibrated equipment [10]. The WC measurement was
taken to the nearest 0.1 cm using a Lufkin executive thin
line tape measure (Lufkin W606PM) (Apex Tool Group,
USA) at the narrowest point between the lower costal
border and the superior iliac crest perpendicular to the
long axis of the trunk. The hip circumference (HC) was
taken at the greatest posterior protuberance of the glu-
teal muscles also to the nearest 0.1 cm.
Blood pressure measurements were taken using an
aneroid sphygmomanometer (Erka, Perfect Aneroid
Clinic 48, Germany) after a rest period of five mi-
nutes in a sitting position. Systolic and diastolic blood
pressure was measured twice, at least 30 min apart,
when participants presented with a very high or low
blood pressure, and the mean of these two measure-
ments recorded. Blood samples, for serum insulin,
glucose and a fasting lipogram, were drawn following
an overnight fast of ten hours.
Criteria for metabolic syndrome classification
For a diagnosis of the MetS, participants had to display
two of the four abnormal criteria with the inclusion of a
raised WC according to the International Diabetes
Foundation (IDF) [11]. The following criteria included:
(a) a compulsory raised WC of ≥94 cm for men and
≥80 cm for women; (b) elevated triglycerides (TG):
>1.7 mmol/l; (c) low high-density lipoprotein-cholesterol
(HDL-c) of <1.03 mmol/l for men and <1.3 mmol/l for
women; (d) raised blood pressure (BP) ≥130/85 mmHg
or on hypertension treatment; and (e) raised fasting
blood glucose (FBG) concentration > 5.6 mmol/l or on
diabetes treatment.
Statistical analysis
Statistical analyses were performed using Statistica ver-
sion 12 software (Statsoft, Tulsa OK, USA). The means
and standard error of the mean (SEM) were calculated
for all parameters, and factorial analysis of variance
(ANOVA) employed to evaluate differences between
various groups. The Bonferroni post hoc test was subse-
quently used to assess the significance of differences
found between groups. Spearman correlations were used
to determine associations between variables. P-values
of ≤ 0.05 were considered statistically significant and the
mean ± SEM was used for all results reported.
Results
Metabolic syndrome-specific participant characteristics
and classifications
From the total n = 191 participants, three participants
withdrew their consent because of time constraints (n =
2 women and n = 1 male). One hundred and forty seven
women (78%) and 41 men (22%) were recruited for this
study which took place between April – June 2015. The
mean age of all participants was 38.78 ± 0.78 years
(37.81 ± 0.87 in women and 42.27 ± 1.68 years in men).
Overall, the prevalence of the MetS (based on the IDF
criteria) was 42.6% (46.3% in women and 29.3% in men)
(Fig. 1). The prevalence of each component of the MetS
in this population was: 56.4% for abdominal obesity as
measured by WC (63.3% in women; 31.7% in men),
23.4% for elevated FBG (23.1% in women; 24.4% in
men), 31.9% for elevated TG level (25.9% in women;
53.7% in men), 56.4% for low HDL-c level (61.2% in
women; 39.0% in men), and 64.9% for hypertension
(65.3% in women; 63.4% in men) (Fig. 2). Statistical sig-
nificant differences were observed for all the indices of
the MetS as displayed in Fig. 3. For WC, both male and
female participants in the MetS group had a significantly
higher WC compared to their non-MetS counterparts
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(p < 0.001 for both). Higher FBG levels were also observed
in the MetS groups, but only significantly higher for the
MetS women (p < 0.001). Similar observations were also
made for systolic and diastolic BP. Significant differences
were observed between all groups for TG levels. Not only
did the male and female MetS participants display signifi-
cantly elevated TG levels compared to their non-MetS
counterparts (p < 0.001), but interestingly enough, men
showed significantly higher TG levels compared to the
women in both the MetS (p < 0.001) and non-MetS (p <
0.05) groups. High-density lipoprotein-cholesterol were
also significantly higher in the non-MetS groups com-
pared to their MetS counterparts in both genders (p <
0.001 for women and p < 0.05 for men).
Although the IDF uses WC as the first risk factor for
categorising a person with the MetS, we were somewhat
concerned regarding the health implications of obesity at
the hand of body mass index (BMI). When men and
women were classified into the different BMI classes
(Table 1), we found that about 40% of the MetS men
were overweight, 40% were obese class I and about 20%
obese class III, whereas the MetS women were almost
equally distributed between the overweight, obese class
I, obese class II and obese class III categories. Of par-
ticular concern were the participants in the non-MetS
groups, especially the women with approximately 61% of
them having a BMI of higher than 25 kg/m2 compared
to 41% of the men without the MetS.
Almost half (48.8%) the MetS population presented
with three risk factors, 35.0% with four and 16.2% with
all five risk factors (Fig. 4a). Figure 4b displays individ-
uals who have zero and up to four risk factors with the
exception of WC as per IDF criteria. The data also indi-
cates more participants were categorized as having the
MetS between the age range 40–49 years (Fig. 5).
Correlations for relationships between body mass indices
and MetS risk factors
To further describe the interactions between the risk
factors of the MetS, correlations were performed which
Fig. 1 Prevalence of the metabolic syndrome in men and women according to IDF criteria
Fig. 2 Prevalence of each component of the metabolic syndrome in the total population, men, as well as women
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indicated significant associations between the three
obesity parameters; BMI, WC and W:H, and the MetS
risk factors, FBG and TG. The majority of significant as-
sociations were evident either for the non-MetS men
non-MetS group or the MetS women. The non-MetS
male group showed significant associations when both
BMI and WC were correlated with FBG (p = 0.039 for
BMI and p = 0.018 for WC) and TG (p = 0.029 for BMI
and p = 0.001 for WC) (Fig. 6). Although only the non-
MetS men displayed significant, but moderate, correla-
tions as seen in Fig. 6a-d, both MetS women and men
showed significant correlations between W:H and FBG
(Fig. 6e), whereas all groups showed a positive associ-
ation between W:H and TG (Fig. 5f ).
Fig. 3 Risk factors according to the IDF criteria for men and women in the MetS and non-MetS groups for (a) waist-circumference; (b) glucose;
(c) triglycerides, (d) HDL-c; (e) systolic BP and (f) diastolic BP. The grey solid lines represent the normal cut-off values according to the IDF
Table 1 Distribution of participants into different BMI classes according to the MetS status and gender
BMI range BMI classification MetS+ Men MetS+ Women MetS- Men MetS- Women TOTAL
<18.5 Underweight 0 0 0 2 2
18.5–24.9 Normal 0 0 17 28 45
25–29.9 Overweight 5 17 11 36 69
30–34.9 Obese class I 5 20 1 3 29
35–39.9 Obese class II 0 17 0 7 24
>40 Obese class III 2 14 0 3 19
TOTAL n = 12 n = 68 n = 29 n = 79 n = 188
Kruger and Nell BMC Public Health  (2017) 17:61 Page 4 of 10
Women in the MetS group’ BMI were significantly,
but moderately, correlated with systolic (p = 0.001) and
diastolic BP (p = 0.01). However, W:H was not signifi-
cantly correlated to either systolic or diastolic BP,
whereas WC was only correlated with systolic BP (p =
0.003) in the female MetS group (Fig. 7).
We also calculated a MetS risk score (RS) for all
groups either without WC (value out of four) or with
WC (value out of five), with the presence of a risk factor
accounting for one RS point. These risk scores were
then correlated with the three obesity indices (Table 2).
In the MetS men a strong negative correlation (p = 0.01)
between the MetS RS and BMI was shown, whereas the
non-MetS men (moderate positive correlation) and the
MetS women (weak positive correlation) showed signifi-
cant associations with WC. A moderate positive correl-
ation was also evident in the MetS female group for
W:H (p = 0.008). For non-MetS women, a weak positive
correlation was only evident when WC was taken into
consideration in the correlation between the MetS RS
and both WC (p = 0.011) and W:H ratio (p = 0.032) with
a trend for BMI (p = 0.054).
Discussion
The prevalence of the MetS is globally on the rise, and
studies have shown that this is also the case for Africa. A
recent study by Hoebel et al. [12] showed that Africans
have the highest prevalence of the MetS compared to
Caucasians. Other African-based studies were also able to
confirm findings of a higher prevalence of the MetS in
South Africa [7, 13], compared to those from other areas
of the world [14–16] and even smaller African countries
themselves such as Nigeria, Ethiopia, Cameroon, Angola
and Tunisia [17–22].
The influence of gender on the development and char-
acterisation of the MetS have not been that well docu-
mented, since the overall prevalence of the MetS,
irrespective of gender, have always been the main con-
cern. However, the ever increasing prevalence of the
MetS, especially amongst the female population, is now
starting to gain much needed attention [7, 8]. This also
holds true for our specific population, since more
women were characterised as having the MetS than
men.
According to the JIS definition, the prevalence of the
MetS in an urban black population of Cape Town was
44.9% in women and 17.3% in men, after adjusting for
age [13]. These statistics were somewhat similar to that
found in our population for both women (46.3%) and
men (29.3%), with the exception of using the IDF defin-
ition. The prevalence of the MetS found by Peer et al.
[13] was much higher than that reported by Motala et
al. [6], which also used the JIS definition in an urban
population. They showed that the prevalence of the
MetS increased with age [6], however for our study par-
ticipants, a highest prevalence of the MetS was noted
between the ages of 40–49 years, followed by a decrease
thereafter.
Similar to our study population, a US-based national
health survey study (NHANES III, 1988–1994) and the
Fig. 4 Distribution of risk factors according to the IDF criteria for participants diagnosed with (a) the metabolic syndrome (b) and those without
the metabolic syndrome
Fig. 5 Distribution of participants with the MetS according to age
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study by Peer et al. [13] indicated that abdominal obes-
ity, elevated TG and low HDL-c was the most promin-
ent risk factors in women [13, 23]. Both these studies, as
well as our study used different diagnostic criteria for
the MetS with similar outcomes. In our female popula-
tion, BP was the most dominant feature (65.3%),
followed closely by WC (63.3%) and HDL-c (61.2%).
These values are lower than those reported by Peer et al.
[13] (central obesity, 86% and low HDL-c, 75%), but it is
expected since they used the JIS and not the IDF defin-
ition. Although the high occurrence of these risk factors
could possible explain the increased prevalence of the
MetS in our female population, this might not necessar-
ily be the case for the male population since we cannot
rule out the fact that the relatively low number of men
who partook in the study could have contributed to the
relatively low prevalence of MetS in the men. Irrespect-
ive, the following three individual risk factors also oc-
curred quite frequently in the men: elevated BP (63.4%),
increased TG (53.7%) and lower HDL-c (39.0%). Similar
to our findings, the NHANES study also concurred that
the combination of increased TG, low HDL-c (22), and
hypertension was most frequent (18.0%), whereas hyper-
tension was the only prevalent parameter in the study by
Peer et al. [13].
Statistical significant gender differences were observed
for all indices of the MetS in our study. Almost all the
MetS risk factors were significantly different between
men and women of the MetS and non-MetS groups with
the exception of FBG and systolic and diastolic BP. Only
TGs showed differences between men and women of the
respective groups, which could be attributed to their tes-
tosterone (T) levels. This is quite likely since a study by
Grosman et al. [24] found a significant but weak nega-
tive correlation between TG levels and T concentrations.
In the aforementioned study, the prevalence of the MetS
also increased as T levels became lower, suggesting that
the men with the MetS will have lower T levels and in
Fig. 6 Correlations showing relationships between body fat indices and the MetS risk factors: a BMI and glucose, (b) BMI and triglycerides, (c) WC
and glucose, (d) WC and triglycerides, (e) W:H and glucose and (f) W:H and triglycerides. Significance are indicated (*) next to the
respective groups
Kruger and Nell BMC Public Health  (2017) 17:61 Page 6 of 10
turn higher TG levels. Furthermore, the higher incidence
of the MetS in subjects with lower T levels was also as-
sociated with abdominal obesity [25–29]. Kaplan et al.
[30] for example examined T levels in n = 864 subjects
with and without the MetS and found that obese men
with the MetS had significantly lower T levels than non-
obese men with or without the MetS. Considering our
findings that the men with the MetS had higher TG
levels compared to the women with the MetS, as well as
the men in the non-MetS group (i.e. those without ab-
dominal obesity), these results corroborates that found
in the studies mentioned above. Although total T might
partially explain why TG’s are elevated in men with the
MetS, estrogen (E2) should also be considered since
around 60% of circulating E2 in men is produced by
aromatisation of T [31, 32]. A recent experimental study
showed that, independent of T, body fat increased when
E2 levels were lower in men. Also, even though both T
and E2 are associated with variations in body compos-
ition in women and men [33, 34], a study by Antonio et
al. [35] found E2 not to be associated with the develop-
ment of the MetS in their male population. Here, in-
stead, lower E2/T ratio, which reflects less aromatisation
of T to E2, was associated with a 62% reduced risk of in-
cident MetS, and was dependent on body fat. This study
further showed that lower T was associated with higher
TG, whereas a lower E2/T ratio was associated with
lower TG. Although these factors were associated with
body fat, total E2 was only associated with higher TG
levels and not body fat. This indicates that changes in
body composition may modify the association between
the E2-androgen balance and MetS, which may account
for discrepancies in the literature regarding E2 and obes-
ity. This fact is in contrast to a study by Wang et al. [36]
Fig. 7 Correlations showing relationships between BMI and systolic and diastolic BP (a and b respectively) and WC and systolic and diastolic BP
(c and d). Significance are indicated (*) next to the respective groups
Table 2 Correlations between the MetS risk scores (RS) and the obesity indices BMI, WC and W:H
Parameters BMI (kg/m2) WC (cm) W:H
MetS Men MetS RS without WC (n = 12) –0.71 (p = 0.01) –0.47 (p = 0.12) 0.39 (p = 0.21)
MetS RS with WC (n = 12) –0.71 (p = 0.01) –0.47 (p = 0.12) 0.39 (p = 0.21)
Non-MetS Men MetS RS without WC (n = 29) 0.29 (p = 0.12) 0.45 (p = 0.013) 0.35 (p = 0.066)
MetS RS with WC (n = 29) 0.36 (p = 0.054) 0.51 (p = 0.005) 0.37 (p = 0.052)
MetS Women MetS RS without WC (n = 68) 0.12 (p = 0.32) 0.27 (p = 0.029) 0.32 (p = 0.008)
MetS RS with WC (n = 68) 0.12 (p = 0.32) 0.27 (p = 0.029) 0.32 (p = 0.008)
Non-MetS Women MetS RS without WC (n = 79) –0.20 (p = 0.073) –0.20 (p = 0.08) 0.023 (p = 0.84)
MetS RS with WC (n = 79) 0.22 (p = 0.054) 0.28 (p = 0.011) 0.24 (p = 0.032)
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which showed that obesity was associated with increased
E2 in men, as well as animal experiments in which a lack
of E2 resulted in increased body fat [37]. Considering
our study population and the fact that participants were
either overweight, obese or had normal body weight,
complicates the current understanding of E2’ effect on
TGs and body weight. It is therefore highly recom-
mended not only measuring E2 and T, but rather the
E2/T ratio in order to fully elucidate the relationship be-
tween sex hormones, obesity and the MetS.
Although literature states that the prevalence of the
MetS differs by age, ethnicity and gender, the population
being studied, as well as the definition used, can also sig-
nificantly adjust the prevalence. What also further com-
plicates this issue is the fact that the syndrome is only
diagnosed whenever three out of the five risk factors are
present, which differs according to the definition used.
This is especially accurate for the African population
since the different criteria for diagnosing the MetS have
not been adapted for either the South African or African
populations [38]. One of the key contributors to the
MetS is WC, and as of yet, no clearly defined ethnic-
specific WC cut-off points have been developed for
Africans, and this may directly impact on the classifica-
tion of the MetS, as it can either over- or underestimate
the prevalence of the MetS in this context. It should also
be noted that an African-based MetS definition with
specific cut-off values for the different risk factors
should be developed in order to accurately estimate the
occurrence of the MetS.
Recent studies have suggested WC and BP cut-off
points for various African populations [6, 39–41], how-
ever, more epidemiological studies are needed to con-
firm that these suggested cut-off points can actually be
used with confidence in the African population. Peer et
al. [13] reported optimal WC cut-off values based on a
black population from Cape Town (83.9 cm men and
94 cm women) and confirmed the findings from Motala
et al. (2011) [6]. However, these cut-off values differ from
what is currently recommended for Africans [11, 42]. The
studies by Peer et al. [13] and Motala et al. [6] furthermore
suggested that current WC cut-off values for Africans
may require change or adaptations depending on the
population used and the specific setting.
We are also aware that genetic background, diet, levels
of physical activity, and levels of over- or undernutrition
also influence the prevalence of both the syndrome and
its components. These issues need to be addressed in
order to fully understand the complexity of the syn-
drome, as well as to enable proper intervention and
treatment programmes.
Our study also needs to recognise some limitations
such as the nature of the study design. The results re-
ported here cannot be generalized to the entire
population, and is limited in its ability to elucidate a
causal relationship between associations. The response
rate for the men participating was very low (22.3%). This
introduces the possibility of a skewed data representa-
tion and further limits the generalizability of the find-
ings. No South-African/African-based definition of the
MetS with specific cut-off values exist, which makes an
accurate estimation of the prevalence of the MetS in this
population difficult. Although dietary and physical activ-
ity data was gathered the data could not be analysed due
to poor reporting from participants.
Conclusion
Evidence shows that the prevalence of the MetS is not
only of global concern, but it is also alarmingly high in
the South African population. This study revealed that
the prevalence of the MetS is indeed high in a farm
workers community of both genders in the Western
Cape of South Africa. This therefore highlights the im-
portance of developing ethnic-based definitions with
clear and different cut-off values for Africans specifically.
Our study also confirmed that the women might be
more at risk of developing the MetS compared to the
men. Future studies should therefore not only focus on
developing specific criteria for Africans, but should also
focus every effort to make individuals aware of the risk
factors and the use of proper therapeutics or other nutri-
tional or exercise interventions for the treatment of the
MetS. It is also important to consider the cardio-
metabolic burden as a consequence of the ever increas-
ing prevalence of the MetS and its risk factors.
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